Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03940820	TitleInvestigación clínica de células CAR-NK específicas de ROBO1 en pacientes con tumores sólidos	Fase Fase 1/Fase 2	Date Added 2019-05-07	Ubicación China	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Células CAR-NK ROBO1	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03874897	TitleChimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.	Fase Fase 1	Date Added 2019-03-14	Ubicación China	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas CAR-CLDN18.2 T-Cells, Chemotherapy, PD-1 Monoclonal Antibody	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06415851	TitleChemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab	Fase Fase 2	Date Added 2024-05-15	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT04262687	TitleChemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate	Fase Fase 2	Date Added 2020-02-10	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab, capecitabine, oxaliplatin, Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT04595266	TitleQuimioembolización (Lifepearls-Irinotecan) en pacientes con cáncer colorrectal y enfermedad metastásica	Fase Fase 2	Date Added 2020-10-20	Ubicación España	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Anti-EGFR or Bevacizumab, FOLFOX regimen, LIVERPEARLS-Irinotecan	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02675946	TitleCGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)	Fase Fase 1	Date Added 2016-02-05	Ubicación California, United States Colorado, United States Connecticut, United States District of Columbia, United States Florida, United States Georgia, United States Hawaii, United States Illinois, United States Indiana, United States Maryland, United States Massachusetts, United States Nebraska, United States New Jersey, United States North Carolina, United States Pennsylvania, United States South Dakota, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States Taiwán	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas cetuximab, CGX1321, encorafenib, Pembrolizumab, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT03727763	TitleCetuximab y vemurafenib más FOLFIRI para el cáncer colorrectal avanzado con mutación BRAF V600E (IMPROVEMENT)	Fase Fase 2	Date Added 2018-11-01	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas cetuximab, Vemurafenib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05291156	TitleCAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy	Fase Fase 2	Date Added 2022-03-22	Ubicación Italia	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Avelumab, cetuximab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03297606	TitleCanadian Profiling and Targeted Agent Utilization Trial (CAPTUR)	Fase Fase 2	Date Added 2017-09-29	Ubicación Canadá	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Axitinib, Bosutinib, Crizotinib, Dasatinib, Erlotinib, Nivolumab plus Ipilimumab, Olaparib, palbociclib, Sunitinib, Temsirolimus, Trastuzumab plus Pertuzumab, Vemurafenib plus Cobimetinib, Vismodegib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05426005	TitleCadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer	Fase Phase 1, Phase 2	Date Added 2022-06-21	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Cadonilimab	Etiquetas MSI-H/ MMRd

Showing 201 to 210 of 299 entries